Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 30.5.2023Teva B.V. (TEV-NL-4)51647Valsartan Teva 160 mg (tbl flm 98x160 mg (blis.PVC/PE/PVDC/Al))29.5.2023O
 29.5.2023Teva B.V. (TEV-NL-4)98219FURON 40 mg (tbl 50x40 mg (blis.PVC/Al))25.5.2023O
 29.5.2023Fresenius Kabi s.r.o. (FRK-CZ-3)37752Sodium chloride Fresenius Kabi 0,9 % (sol inf 20x250 ml (fľ.LDPE - KabiPac))31.5.2023R
 29.5.2023Fresenius Kabi s.r.o. (FRK-CZ-3)1551CBenelyte (sol inf 20x250 ml (fľ.LDPE))1.6.2023R
 29.5.2023Fresenius Kabi s.r.o. (FRK-CZ-3)76541Piperacillin/Tazobactam Kabi 4 g/0,5 g (plv ifo 10x4 g/0,5 g (liek.inj.skl.))1.6.2023R
 29.5.2023CANDE s.r.o. (CRR-SK)4367DINOMED 50 mg/ml sirup (sir 1x150 ml (fľ.skl.jantárová))29.5.2023O
 29.5.2023CANDE s.r.o. (CRR-SK)3805BDUTAMED 0,5 mg (cps mol 90x0,5 mg (blis.PVC/PVDC/Al))29.5.2023O
 29.5.2023B.Braun Melsungen AG (BME)32440Chlorid sodný B. Braun 0,9 % injekčný roztok (sol inj 100x20 ml (amp.PP))26.5.2023Z
 29.5.2023URSAPHARM Arzneimittel GmbH (URS-1)12967Kanamycin-POS (ung oph 1x2,5 g (tuba Al))1.7.2023R
 29.5.2023GlaxoSmithKline (Ireland) Limited (GAG-IE-2)09505Benlysta 400 mg prášok na infúzny koncentrát (plc ifc 1x400 mg (liek.inj.skl.))26.5.2023R
 29.5.2023Zentiva, k.s. (ZNT-1)2006EToletate (imp sip 1x10,72 mg (striek.inj.napl.plast.))29.5.2023U
 29.5.2023Johnson & Johnson, s.r.o. (JHN-SK-1)49924Concerta 36 mg tablety s predĺženým uvoľňovaním (tbl plg 30x36 mg (fľ.HDPE))29.5.2023R
 29.5.2023Belupo lijekovi i kozmetika d.d. (BEU)2572DBELODUT (cps dur 90x0,5 mg/0,4 mg (fľ.HDPE))29.5.2023O
 29.5.2023Cipla Europe NV (CIA-BE-2)26478Alerid (tbl flm 100x10 mg)29.5.2023R
 29.5.2023Cipla Europe NV (CIA-BE-2)64867Alerid (tbl flm 20x10 mg)29.5.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To